New York (GenomeWeb) – The US Food and Drug Administration has granted Emergency Use Authorization to a Zika test from Roche that runs on the firm's LightCycler 480 Instrument II or Cobas z 480 Analyzer.

The LightMix Zika real-time RT-PCR Test is an easy-to-use molecular diagnostic test that enables healthcare professionals to quickly detect viral RNA in plasma or serum of patients meeting US Centers for Disease Control and Prevention clinical or epidemiological criteria, Roche said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jul
24
Sponsored by
Qiagen

In this webinar, Dr. Fergus Couch from the Mayo Clinic will present data from a large study that used a targeted sequencing panel to determine pancreatic cancer risk associated with inherited mutations in several cancer predisposition genes.

Jul
25
Sponsored by
Streck

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms. 

Aug
09

In this two-part webinar, Dr. Elin Gray, from Edith Cowan University, and Ms. Weiwei Zhao, from Kingmed diagnostic, will compare the highly sensitive, multiplexed UltraSEEK technology, on the MassARRAY system, to digital droplet PCR (ddPCR) results on melanoma and non-small cell lung carcinoma samples.